Tidal Investments LLC boosted its position in shares of Balchem Co. (NASDAQ:BCPC – Free Report) by 10.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 7,975 shares of the basic materials company’s stock after acquiring an additional 761 shares during the quarter. Tidal Investments LLC’s holdings in Balchem were worth $1,404,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. grew its stake in shares of Balchem by 1.5% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock valued at $604,000 after buying an additional 59 shares during the last quarter. Raymond James & Associates increased its stake in Balchem by 1.9% in the second quarter. Raymond James & Associates now owns 50,348 shares of the basic materials company’s stock worth $7,751,000 after purchasing an additional 927 shares during the period. Louisiana State Employees Retirement System lifted its position in shares of Balchem by 1.9% during the second quarter. Louisiana State Employees Retirement System now owns 16,300 shares of the basic materials company’s stock worth $2,509,000 after purchasing an additional 300 shares during the last quarter. Argent Capital Management LLC lifted its position in shares of Balchem by 61.6% during the second quarter. Argent Capital Management LLC now owns 3,629 shares of the basic materials company’s stock worth $559,000 after purchasing an additional 1,384 shares during the last quarter. Finally, Tributary Capital Management LLC boosted its stake in shares of Balchem by 0.3% during the second quarter. Tributary Capital Management LLC now owns 135,185 shares of the basic materials company’s stock valued at $20,812,000 after purchasing an additional 364 shares during the period. 87.91% of the stock is owned by hedge funds and other institutional investors.
Balchem Trading Down 3.4 %
Shares of NASDAQ BCPC opened at $166.53 on Thursday. Balchem Co. has a twelve month low of $135.84 and a twelve month high of $186.03. The firm has a market cap of $5.41 billion, a PE ratio of 44.77, a price-to-earnings-growth ratio of 5.32 and a beta of 0.67. The business has a fifty day simple moving average of $175.31 and a two-hundred day simple moving average of $169.57. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.
Balchem Increases Dividend
Analyst Ratings Changes
Several research analysts recently commented on the stock. HC Wainwright raised their price target on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th.
View Our Latest Report on Balchem
Balchem Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Read More
- Five stocks we like better than Balchem
- How to Buy Cheap Stocks Step by Step
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 3 Best Fintech Stocks for a Portfolio Boost
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Conference Calls and Individual Investors
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.